Claudia Seikrit

741 total citations · 1 hit paper
19 papers, 333 citations indexed

About

Claudia Seikrit is a scholar working on Nephrology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Claudia Seikrit has authored 19 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Nephrology, 4 papers in Pathology and Forensic Medicine and 4 papers in Hematology. Recurrent topics in Claudia Seikrit's work include Renal Diseases and Glomerulopathies (13 papers), Chronic Kidney Disease and Diabetes (5 papers) and Platelet Disorders and Treatments (4 papers). Claudia Seikrit is often cited by papers focused on Renal Diseases and Glomerulopathies (13 papers), Chronic Kidney Disease and Diabetes (5 papers) and Platelet Disorders and Treatments (4 papers). Claudia Seikrit collaborates with scholars based in Germany, Sweden and Netherlands. Claudia Seikrit's co-authors include Jürgen Floege, Peter Boor, Eleni Stamellou, Jonathan Barratt, Vladimı́r Tesař, Uta Kunter, Frank Eitner, Oliver Pabst, Sydney Tang and Rafael Kramann and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and Nature Reviews Disease Primers.

In The Last Decade

Claudia Seikrit

19 papers receiving 329 citations

Hit Papers

IgA nephropathy 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia Seikrit Germany 10 210 72 58 56 53 19 333
Hee Yeon Cho South Korea 11 184 0.9× 69 1.0× 71 1.2× 67 1.2× 54 1.0× 13 328
Masami Fujisaki Japan 7 180 0.9× 65 0.9× 56 1.0× 33 0.6× 70 1.3× 8 291
Yanna Dou China 9 134 0.6× 84 1.2× 43 0.7× 61 1.1× 29 0.5× 25 326
Yoshie Sasatomi Japan 13 228 1.1× 117 1.6× 42 0.7× 95 1.7× 38 0.7× 25 410
Zhuxing Sun China 11 208 1.0× 71 1.0× 26 0.4× 78 1.4× 74 1.4× 26 341
Zheng Tang China 10 215 1.0× 67 0.9× 57 1.0× 109 1.9× 32 0.6× 25 288
Ari Shimizu Japan 12 280 1.3× 52 0.7× 48 0.8× 69 1.2× 88 1.7× 29 381
Kan Katayama Japan 12 173 0.8× 162 2.3× 43 0.7× 71 1.3× 32 0.6× 52 461
Christine M. Logar United States 8 246 1.2× 125 1.7× 53 0.9× 47 0.8× 28 0.5× 13 414
Lixia Xu China 13 266 1.3× 113 1.6× 141 2.4× 60 1.1× 73 1.4× 30 464

Countries citing papers authored by Claudia Seikrit

Since Specialization
Citations

This map shows the geographic impact of Claudia Seikrit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Seikrit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Seikrit more than expected).

Fields of papers citing papers by Claudia Seikrit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Seikrit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Seikrit. The network helps show where Claudia Seikrit may publish in the future.

Co-authorship network of co-authors of Claudia Seikrit

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Seikrit. A scholar is included among the top collaborators of Claudia Seikrit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Seikrit. Claudia Seikrit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Schanz, Moritz, Claudia Seikrit, Bernd Hohenstein, et al.. (2024). First real-world evidence of sparsentan efficacy in patients with IgA nephropathy treated with SGLT2 inhibitors. Clinical Kidney Journal. 18(1). sfae394–sfae394. 2 indexed citations
2.
Cheng, Mingbo, Vera Jankowski, Ina V. Martin, et al.. (2024). Lineage tracing reveals transient phenotypic adaptation of tubular cells during acute kidney injury. iScience. 27(3). 109255–109255. 1 indexed citations
3.
Stamellou, Eleni, Claudia Seikrit, Sydney Tang, et al.. (2023). IgA nephropathy. Nature Reviews Disease Primers. 9(1). 67–67. 81 indexed citations breakdown →
4.
Kunter, Uta, Claudia Seikrit, & Jürgen Floege. (2023). Novel agents for treating IgA nephropathy. Current Opinion in Nephrology & Hypertension. 32(5). 418–426. 10 indexed citations
5.
Muto, Masahiro, Jeremy R. Glissen Brown, Karen Molyneux, et al.. (2023). Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial. Kidney International. 105(2). 381–388. 26 indexed citations
6.
Seikrit, Claudia, Judith Schimpf, Stephanie Wied, et al.. (2022). Intestinal permeability in patients with IgA nephropathy and other glomerular diseases: an observational study. Journal of Nephrology. 36(2). 463–474. 10 indexed citations
7.
Gupta, Laxmi, Barbara M. Klinkhammer, Claudia Seikrit, et al.. (2022). Large-scale extraction of interpretable features provides new insights into kidney histopathology – A proof-of-concept study. Journal of Pathology Informatics. 13. 100097–100097. 8 indexed citations
8.
Seikrit, Claudia & Oliver Pabst. (2021). The immune landscape of IgA induction in the gut. Seminars in Immunopathology. 43(5). 627–637. 17 indexed citations
9.
Seikrit, Claudia, Eva Miriam Buhl, Róbert Gáspár, et al.. (2021). A Hypercaloric Diet Induces Early Podocyte Damage in Aged, Non-Diabetic Rats. Cellular Physiology and Biochemistry. 55(S4). 96–112. 1 indexed citations
10.
Villa, Luigi, Thilo Krüger, Claudia Seikrit, et al.. (2021). Time on previous renal replacement therapy is associated with worse outcomes of COVID-19 in a regional cohort of kidney transplant and dialysis patients. Medicine. 100(10). e24893–e24893. 7 indexed citations
11.
Seikrit, Claudia, Thomas Rauen, Eleni Stamellou, & Jürgen Floege. (2021). Precision medicine in immunoglobulin A nephropathy: still a journey ahead. Nephrology Dialysis Transplantation. 36(Supplement_2). 24–30. 5 indexed citations
12.
Seikrit, Claudia, Stephanie Wied, Christina Fitzner, et al.. (2020). Single versus dual blockade of the renin-angiotensin system in patients with IgA nephropathy. Journal of Nephrology. 33(6). 1231–1239. 17 indexed citations
13.
Rauen, Thomas, Claudia Seikrit, Stephanie Wied, et al.. (2020). SAT-395 DUAL BLOCKADE OF THE RENIN-ANGIOTENSIN SYSTEM IN PATIENTS WITH IgA NePHROPATHY. Kidney International Reports. 5(3). S165–S166. 2 indexed citations
14.
Seikrit, Claudia, Thomas Rauen, & Jürgen Floege. (2020). IgA-Nephropathie. Der Nephrologe. 15(6). 336–342. 3 indexed citations
15.
Seikrit, Claudia, Thomas Rauen, & Jürgen Floege. (2019). Immunglobulin-A-Nephropathie. Der Internist. 60(5). 432–439. 7 indexed citations
16.
Roderburg, Christoph, Alexander Koch, Frank Tacke, et al.. (2013). Serum concentrations of A Proliferation-Inducing Ligand (APRIL) are elevated in sepsis and predict mortality in critically ill patients. Journal of Critical Care. 28(5). 882.e1–882.e11. 11 indexed citations
17.
Seikrit, Claudia, Claudia R.C. van Roeyen, Dirk Bokemeyer, et al.. (2012). Biological responses to PDGF-AA versus PDGF-CC in renal fibroblasts. Nephrology Dialysis Transplantation. 28(4). 889–900. 15 indexed citations
18.
Seikrit, Claudia, Anja Mühlfeld, Hermann-Josef Groene, & Jürgen Floege. (2010). Renal allograft failure in a hyperparathyroid patient following initiation of a calcimimetic. Nature Reviews Nephrology. 7(4). 237–241. 13 indexed citations
19.
Eitner, Frank, Claudia van Roeyen, Uta Kunter, et al.. (2008). PDGF-C Is a Proinflammatory Cytokine that Mediates Renal Interstitial Fibrosis. Journal of the American Society of Nephrology. 19(2). 281–289. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026